Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A3H2184
Thu, 21.01.2021
Epigenomics AG
Epigenomics AG Plans to Challenge NCD Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer Screening
Company evaluating all options to challenge CMS' decision to non-cover the Epi proColon test
New blood-based test demonstrates performance characteristics that would satisfy the latest sensitivity and specificity requ [ … ]